Weil, Gotshal & Manges LLP‘s Diane Sullivan is sought after by clients facing class action and MDL proceedings concerning product liability, including representing GSK in claims alleging that the prescription drug Zantac caused cancer, where she was able to secure a settlement covering most claims in October 2024. Sullivan was also retained by L’Oréal to lead its defense in an MDL where plaintiffs allege its hair relaxer products caused breast and uterine cancers, and is also engaged by Johnson & Johnson and Imerys Talc America in the latter’s Ch. 11 proceedings, tied to claims that J&J’s talc products caused ovarian cancer and mesothelioma. Sullivan is based in the firm’s New York office.
L'éditorial du Legal 500
- Profil